- Home
- ALEC vs MAV Comparison
ALEC vs MAV Comparison
Compare ALEC & MAV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ALEC
- MAV
- Stock Information
- Founded
- ALEC 2013
- MAV 2003
- Country
- ALEC United States
- MAV United States
- Employees
- ALEC N/A
- MAV N/A
- Industry
- ALEC Biotechnology: Biological Products (No Diagnostic Substances)
- MAV Finance Companies
- Sector
- ALEC Health Care
- MAV Finance
- Exchange
- ALEC Nasdaq
- MAV Nasdaq
- Market Cap
- ALEC 176.3M
- MAV 202.6M
- IPO Year
- ALEC 2019
- MAV N/A
- Fundamental
- Price
- ALEC $1.73
- MAV $8.56
- Analyst Decision
- ALEC Buy
- MAV
- Analyst Count
- ALEC 6
- MAV 0
- Target Price
- ALEC $11.75
- MAV N/A
- AVG Volume (30 Days)
- ALEC 1.3M
- MAV 66.2K
- Earning Date
- ALEC 02-25-2025
- MAV 01-01-0001
- Dividend Yield
- ALEC N/A
- MAV 4.30%
- EPS Growth
- ALEC N/A
- MAV N/A
- EPS
- ALEC N/A
- MAV N/A
- Revenue
- ALEC $61,508,000.00
- MAV N/A
- Revenue This Year
- ALEC N/A
- MAV N/A
- Revenue Next Year
- ALEC $4.98
- MAV N/A
- P/E Ratio
- ALEC N/A
- MAV N/A
- Revenue Growth
- ALEC N/A
- MAV N/A
- 52 Week Low
- ALEC $1.60
- MAV $6.37
- 52 Week High
- ALEC $7.58
- MAV $8.34
- Technical
- Relative Strength Index (RSI)
- ALEC 34.59
- MAV 50.88
- Support Level
- ALEC $1.60
- MAV $8.43
- Resistance Level
- ALEC $1.82
- MAV $8.55
- Average True Range (ATR)
- ALEC 0.14
- MAV 0.08
- MACD
- ALEC 0.05
- MAV 0.01
- Stochastic Oscillator
- ALEC 23.42
- MAV 87.50
About ALEC Alector Inc.
Alector Inc is a clinical-stage biopharmaceutical company. It is engaged in developing a novel therapeutic approach for the treatment of neurodegeneration. The firm is involved in developing therapies that are designed to simultaneously counteract pathologies by restoring healthy immune function to the brain. Its pipeline products include AL001, AL002, AL003, and AL101.
About MAV Pioneer Municipal High Income Advantage Fund Inc.
Pioneer Muni High Income Advantage Tr is a closed-end fund designed to pursue high current income exempt from regular federal income tax and as a secondary objective to seek capital appreciation. It predominantly invests in debt securities and other obligations issued by or on behalf of states, territories, and possessions of the United States and the District of Columbia and their political subdivisions, agencies, and instrumentalities, the interest on which is exempt from regular federal income tax.